| 
                        
			 | 
			 
			
                        
                        
                
      Office Locations: 
                         
 | 
1751 River Run, Ste 400 
Fort Worth, TX 76107 
Phone: 817-984-5964 
 
 
 |  |  |  
			 
			 | 
			 
			
			| 
			
			 | 
			 
			
			
			
			| 
			
			 | 
			
			 
			  
			
 Life Sciences & Healthcare
Medical Device
			
			 
			 | 
			 
			 | 
			 
			
			
			
			
			| 
			
			 | 
			
			 
			  
			
Bios Partners is a venture capital firm focused on investing in early-stage biopharmaceutical and medical device companies. Founded in 2014 and based in Fort Worth, TX, the firm utilizes an experienced team of industry professionals to actively collaborate with its investment portfolio companies and enhance stakeholder value. The team has over 90 years of combined experience.
			 
			 
			 | 
			 
			 | 
			 
			
			| 
			
			 | 
			 
			 
 | 
                         | 
                         | 
                                      
                                
                                
                                                       
                                 
                                
                                Investment Firm Key
                                 
                                 
                                   VC = Venture Capital 
                                   PE = Private Equity 
                                   A = Angel 
                                   I = Incubator 
                                   MB = Merchant Bank 
                                   VD = Venture Debt 
                                   FI = Family Investment Office 
                                   FOF = Fund of Funds 
                                   ED = Economic Development Office    
                                   TT = Technology Transfer Office 
                                   CVC = Corporate Venture Capital 
                                   SEC = Secondary Purchaser 
                                   HF = Hedge Fund/Mutual Fund 
                                    
                                 | 
                                 
                                
                                
                                
                                
                                    
                                    
                                 | 
                                 
                                
                                
                                
                                
                                
                                | COMPANY STAGE | REVENUE | 
                                 
                                
                                | Venture Capital |  | 
                                 
                                
                                Seed Stage (includes "pre-seed," or  concept stage) | No Revenue | 
                                 
                                
                                | Early Stage | Minimal Revenue | 
                                 
                                
                                Growth Stage (also called Mid-stage) | $2M-$7M | 
                                 
                                
                                Expansion Stage (also called Late-stage) | $7M and greater | 
                                 
                                
                                | Private Equity |  | 
                                 
                                
                                | Lower Middle Market | $10M-$249M | 
                                 
                                
                                | Middle Market | $250M-$499M | 
                                 
                                
                                | Upper Middle Market | $500M-$1B | 
                                 
                                
                                | Large Cap | >$1B | 
                                 
                                 
                                 
                                 |  
                                
                                
                                    
                                    
                                 | 
                                 
                                
                                | 
                                
                                 | 
                                 
                                 
 |